Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01810614 · ClinicalTrials.gov registry record · NA
A New Diet for Patients With Autosomal Dominant Polycystic Disease (ADPKD)
A NA study, sponsored by University of Kansas.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT01810614 is a NA study that has completed, run by University of Kansas. The registered enrollment target is 12 participants.
The verdict
NCT01810614, a NA study, has completed, sponsored by University of Kansas.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
Recent evidence has shown that kidney volume predicts the likelihood of developing renal insufficiency over a finite length of time in ADPKD, suggesting a linkage between the growth of cysts and the harm they do to kidney function. Recent studies indicate that the rate of kidney volume increase is hastened by excess dietary protein, salt, and potential net acid precursors, and slowed by increased water intake sufficient to lower plasma vasopressin levels. Diets are commonly prescribed to treat ADPKD and other renal patients with disease near the end-stage, but there is currently no specific diet prescription that takes potentially harmful dietary elements into account for ADPKD patients in the earliest stages of the disease. This study will examine a novel diet for ADPKD created by the researcher termed the ADPKD diet.
Interventions
- OTHER ADPKD Diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2013-02 |
| Est. Completion | 2014-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01810614
The ClinicalTrials.gov registry entry for NCT01810614 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Kansas, which has 66 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ADPKD Diet is the first listed.
NCT01810614 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01810614 about?
NCT01810614 is a clinical study titled "A New Diet for Patients With Autosomal Dominant Polycystic Disease (ADPKD)". Recent evidence has shown that kidney volume predicts the likelihood of developing renal insufficiency over a finite length of time in ADPKD, suggesting a linkage between the growth of cysts and the harm they do to kidney function. Recent studies indicate that the rate of kidney volume increase is h...
What is the current status of trial NCT01810614?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2013-02. Estimated completion is 2014-11.
What interventions are being tested in trial NCT01810614?
The interventions under investigation include: ADPKD Diet (OTHER).
Who is sponsoring clinical trial NCT01810614?
This trial is sponsored by University of Kansas, which has 66 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.